Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Patricia L. Rubio"'
Autor:
Jorge Rossi, Edgardo M Baialardo, Patricia L. Rubio, María A. Deu, Cristian G. Sánchez La Rosa, Elizabeth M. Alfaro, Pedro Zubizarreta, Carla L Pennella, Maria S. Felice, Myriam Guitter, Cristina N. Alonso
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(10)
Background Infant acute lymphoblastic leukemia (ALL) is an infrequent disease characterized by clinical and biological features related to poor prognosis. Adapted therapies were designed without a clear consensus regarding the best treatment options.
Autor:
Gladys Gutierrez, Patricia L. Rubio, Myriam Guitter, Maria S. Felice, Marta S. Gallego, Carlos M. Figueroa Turienzo, María L. Galluzzo, Cristian G. Sánchez La Rosa, Pedro Zubizarreta, Natalia Millan, Viviana Herzovich, Walter Cacciavillano, Guillermo L. Chantada, Cristina N. Alonso, Adriana Rose, Fabiana Lubieniecki, Daniel Alderete, Elizabeth M. Alfaro, Jorge Rossi
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:e406-e412
Introduction Childhood acute leukemias (AL) and lymphomas achieve good survival rates. However, second neoplasms (SN) are a devastating event. Methods From August 1987 to December 2016, 34 of 3321 (1%) patients with diagnosis of AL or lymphoma develo
Autor:
Marcin Braun, Grigory Tsaur, Larisa Fechina, Rob Pieters, Ingegerd Ivanov Öfverholm, Lina Hamadeh, Karin Nebral, Gisela Barbany, Jan Stary, Maria S. Felice, Mariana Emerenciano, Mio Yano, Marta Jeison, Sarah Elitzur, Monique L. den Boer, Henriett Pikó, Luciano Dalla Pozza, Gabor G. Kovacs, Maria S. Pombo-de-Oliveira, Wojciech Młynarski, Roland P. Kuiper, Keizo Horibe, Rosemary Sutton, Sabine Strehl, Amir Enshaei, Nicola C. Venn, Agata Pastorczak, Eva Fronkova, Judith M. Boer, Patricia L. Rubio, Anthony V. Moorman, Irén Haltrich, Andishe Attarbaschi, Cristina N. Alonso, Ajay Vora, Mats Heyman, Jan Trka, Claire Schwab, Christine J. Harrison, Toshihiko Imamura
Publikováno v:
Blood Advances, 3, 2, pp. 148-157
Blood Advances, 3, 148-157
Blood Advances, 3, 148-157
Contains fulltext : 204641.pdf (Publisher’s version ) (Open Access) Genetic abnormalities provide vital diagnostic and prognostic information in pediatric acute lymphoblastic leukemia (ALL) and are increasingly used to assign patients to risk group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf3dd283d1b3cc4b5b525fddbefd790
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/204641
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/204641
Autor:
Silvia Eandi-Eberle, Patricia L. Rubio, Mariela C. Coccé, Sophia Polychronopoulou, Vassilios Papadakis, Stefanos I. Papadhimitriou, George Paterakis, Marta S. Gallego, Cristina N. Alonso, Loizos Petrikkos, Andrea Bernasconi, Maria S. Felice, Jorge Rossi, Adrian P. Mansini, E.O. Sajaroff, Maria Ampatzidou
Publikováno v:
Leukemia & Lymphoma. 57:2289-2297
The association between mature-B phenotype and MLL abnormalities in acute lymphoblastic leukemia (ALL) is a very unusual finding; only 14 pediatric cases have been reported so far. We describe the clinical and biological characteristics and outcome o
Autor:
Raquel Mitchell, Jorge Rossi, Myriam Guitter, Angelica Fernandez-Barbieri, Patricia L. Rubio, Andrea Bernasconi, Edgardo M Baialardo, Silvia Eandi-Eberle, Maria S. Felice, E.O. Sajaroff, Cristina N. Alonso, Jorge Alberto Digiorge
Publikováno v:
Leukemia research. 71
Several conventions have been established in order to define and characterize Mixed Phenotype Acute Leukemia (MPAL). However, megakaryocytic markers have not been included in the definition of MPAL neither in the European Group for the Immunological
Autor:
Maria A. Rampazzi, Andrea Bernasconi, Cristina N. Alonso, Adriana Medina, Marta S. Gallego, Patricia L. Rubio, Silvia Eandi Eberle, Jorge Rossi, Mariela C. Coccé, Maria S. Felice
Publikováno v:
Molecular Syndromology. 6:193-203
The purpose of the current study was to evaluate the cytogenetic findings in 1,057 children with acute lymphoblastic leukemia (ALL) referred to the cytogenetics laboratory at the Hospital de Pediatría Dr. Juan P. Garrahan, between 1991 and 2014. Chr
Autor:
Adrian P. Mansini, Marta S. Gallego, Cristina N. Alonso, Jorge Rossi, Adriana Medina, Pedro Zubizarreta, Patricia L. Rubio, Maria S. Felice
Publikováno v:
Archivos Argentinos de Pediatria. 111:532-536
Patients with Down's Syndrome have a higher risk of developing acute megakaryoblastic leukemia (AML). Ten per cent of newborn infants with this syndrome have transient abnormal myelopoiesis (TAM), indistinguishable from AML, which generally remits sp
Autor:
Marta S. Gallego, Maria S. Felice, Jorge Rossi, Pedro Zubizarreta, Patricia L. Rubio, Mariela C. Coccé, Andrea Bernasconi, Myriam R. Guitter, Elizabeth M. Alfaro, Cristina N. Alonso, Silvia Eandi Eberle
Publikováno v:
Leukemialymphoma. 57(9)
Childhood acute myeloid leukemia (AML) achieves event-free-survival (EFS) rates of ∼50%. Double induction phase has been introduced for improving these results. Four consecutive protocols for AML treatment were evaluated to assess the impact of the
Autor:
Patricia L. Rubio, Jorge Rossi, Cristina N. Alonso, Marta S. Gallego, Elizabeth M. Alfaro, Maria S. Felice, Myriam R. Guitter, Andrea Bernasconi, Pedro Zubizarreta
Publikováno v:
Leukemia & Lymphoma. 52:1215-1221
Historically, t(1;19)(q23;p13.3) has been related to pre-B acute lymphoblastic leukemia (ALL) and associated with a poor prognosis. Current treatments have overcome this dismal outcome, but advantages in survival for the unbalanced group have been re
BTBD18: A novel MLL partner gene in an infant with acute lymphoblastic leukemia and inv(11)(q13;q23)
Autor:
Cristina N. Alonso, Marta S. Gallego, Jorge Rossi, Rolf Marschalek, Claus Meyer, Maria S. Felice, Adrian P. Mansini, Patricia L. Rubio, Adriana Medina
Publikováno v:
Leukemia Research. 34:e294-e296